SOPHiA GENETICS SA (SOPH) Statistics

SOPHiA GENETICS SA (SOPH) is a company that specializes in genomic data analytics and artificial intelligence. The company is headquartered in Saint-Sulpice, Switzerland, and was founded in 2011. SOPHiA GENETICS uses its proprietary technology to analyze genomic data and provide insights for healthcare providers and researchers. The company's platform, called SOPHiA AI, combines genomic and clinical data to help diagnose and treat diseases. SOPHiA AI is used in more than 850 hospitals worldwide, and has analyzed over 570,000 patient genomes. The company's mission is to democratize Data-Driven Medicine and unlock the power of every patient's data.

When it comes to valuation metrics, SOPHiA GENETICS SA has a market capitalization of X, indicating its total market value. The company is trading at a price-to-earnings ratio of X, which shows the relationship between the stock price and the company's earnings per share. In terms of fundamentals, SOPHiA GENETICS has a strong financial position. The company has a revenue per share of X and a profit margin of X. This indicates that SOPHiA GENETICS is generating solid revenue and has good profitability. In terms of debt, the company has a total debt of X. However, it is important to note that SOPHiA GENETICS has a gross profit of X, which indicates that the company is able to generate a significant amount of profit after covering its costs.